NCT01763151

Brief Summary

With increasing demands of patients concerning refractive outcome after cataract surgery, toric intraocular lenses (IOLs) that correct corneal astigmatism have been introduced more widely to cataract surgery. Originally toric IOLs were used mainly for patients with high degrees of astigmatism, especially after corneal surgical procedures such as penetrating keratoplasty. Since a couple of years, toric IOLs are available from numerous manufacturers to correct lower amounts of astigmatism which are much more prevalent with about 30% having a corneal astigmatism of 0.75D or more in the cataract population. This should result in less spectacle dependence of patients due to the astigmatic correction. The alternative method to reduce corneal astigmatism as part of cataract surgery is to make incisions on the steeper axis of the cornea such as limbal relaxing incisions or an additional clear corneal incision opposite (OCCI) to the main cataract opening. These techniques are in use since more than 2 decades and are widely used in clinical routine. As with toric IOLs, precise alignment of the cuts with the axis of astigmatism is essential. The disadvantage of the incisional techniques is the variability of the effect between patients since it depends on factors such as the extent of scaring of the cuts after surgery as well as corneal thickness. The main advantage is the simplicity of the technique and the lower cost. Aim of this study is to compare toric IOL implantation and opposite clear corneal incision during cataract surgery to correct corneal astigmatism.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Sep 2010

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2010

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2012

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 6, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 8, 2013

Completed
Last Updated

January 10, 2013

Status Verified

January 1, 2013

Enrollment Period

1.9 years

First QC Date

January 6, 2013

Last Update Submit

January 8, 2013

Conditions

Keywords

cataract surgery, astigmatism, opposite clear corneal incision, toric IOL, IOL rotational stability

Outcome Measures

Primary Outcomes (1)

  • Postoperative residual astigmatism

    9 months post-operatively

Secondary Outcomes (1)

  • uncorrected distance visual acuity (UDVA)

    9 months post-operatively

Other Outcomes (1)

  • postoperative IOL rotation

    3 months and 9 months post-operatively

Study Arms (2)

toric IOL

ACTIVE COMPARATOR

aspherical, toric acrylic IOL (Lentis L-312T, Oculentis, Germany)

Device: toric IOL

IOL combined with opposite clear corneal incision (OCCI)

ACTIVE COMPARATOR

aspherical, acrylic IOL with OCCI

Procedure: IOL combined with opposite clear corneal incision (OCCI)

Interventions

toric IOLDEVICE

implantation of an aspheric, toric, acrylic IOL during cataract surgery

toric IOL

aspherical, acrylic IOL with opposite clear corneal incision during cataract surgery

IOL combined with opposite clear corneal incision (OCCI)

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Cataract
  • Age 21 and older
  • Regular corneal astigmatism 1.0 up to 2.5 D
  • written informed consent prior to surgery

You may not qualify if:

  • Relevant other ophthalmic diseases such as: pseudoexfoliation, glaucoma, traumatic cataract corneal scars, and other co-morbidity that could affect capsule bag stability ( e.g. Marfan syndrome)
  • Irregular corneal astigmatism on corneal topography

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital

Vienna, 1140, Austria

Location

MeSH Terms

Conditions

CataractAstigmatism

Condition Hierarchy (Ancestors)

Lens DiseasesEye DiseasesRefractive Errors

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, MBA

Study Record Dates

First Submitted

January 6, 2013

First Posted

January 8, 2013

Study Start

September 1, 2010

Primary Completion

August 1, 2012

Study Completion

December 1, 2012

Last Updated

January 10, 2013

Record last verified: 2013-01

Locations